Dr. Sarah Hadique, MD

Dr. Hadique practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Dr. Hadique's NPI, 1073715827, was assigned on June 4, 2007. Dr. Hadique holds West Virginia license 23216.

Dr. Hadique's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Dr. Hadique's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Dr. Hadique is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Dr. Hadique to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hadique practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Hadique's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Hadique is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Hadique is licensed in West Virginia.

CMS data shows 457 Medicare services from Dr. Hadique across 10 procedure codes in 2024, for 263 Medicare patients. Medicare paid $45,545 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 263 Medicare patients who saw Dr. Hadique in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hadique's median patient age at 69, with 46% women.

In 2024, Dr. Hadique wrote 755 Medicare Part D claims for 82 patients. 57% of them were for generic drugs. CMS names the drug for 671 of them, across 16 drugs with 11 or more claims each, at $241,777 in total drug cost. In 2023, CMS named 602 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Hadique for performance year 2024, reported through an alternative payment model (APM). Dr. Hadique accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hadique as offering telehealth.

Dmand AI links 13 papers to Dr. Hadique, published from 2019 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Biopsy, Critical Illness and Intensive Care Units. Dr. Hadique has published most often in Respir Med Case Rep. Dr. Hadique's most frequent co-authors are Rahul G. Sangani, MD, Michael Forte, MD and Haroon Ahmed, MD.

CMS Open Payments shows 16 general payments to Dr. Hadique from 7 drug and device companies from 2016 to 2025. Education make up the largest share, 55% of the total. Intuitive Surgical, Inc. paid the most, $3,460.